June 16, 2014 Press release Mitsubishi Tanabe Pharma Corporation Positive Phase 3 Results of Canagliflozin in Japanese Patients with Type 2 Diabetes at American Diabetes Association

First Page		Document Content
Date: 2014-06-15 21:20:21 Medicine Diabetes management Glycated hemoglobin Diabetes mellitus type 2 Diabetes mellitus Diabetes Endocrine system Health		June 16, 2014 Press release Mitsubishi Tanabe Pharma Corporation Positive Phase 3 Results of Canagliflozin in Japanese Patients with Type 2 Diabetes at American Diabetes Association Add to Reading List Source URL: www.mt-pharma.co.jp Download Document from Source Website File Size: 45,26 KB Share Document on Facebook

	CMTF005 - Food is Medicine - Checklist_Debranded DocID: 1xVMk - View Document
	Pacemakers and Implantable Cardiac Defibrillators: Software Radio Attacks and Zero-Power Defenses Daniel Halperin† Thomas S. Heydt-Benjamin† DocID: 1xVge - View Document
	CMTF005 - Food is Medicine - Checklist_Debranded_with bleed DocID: 1xUza - View Document
	CMTF005 - Food is Medicine - Checklist_Debranded_edited DocID: 1xTtU - View Document
	PDF Document DocID: 1xSqy - View Document